# Tack Optimized Drug Coated Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries

Study · id `cardio:ct-nct02802306` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02802306](<https://clinicaltrials.gov/study/NCT02802306>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02802306

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 201 participants.

## Technical summary

Registry record NCT02802306. Allocation not applicable; no masking; primary purpose treatment. Start 2016-06 (registry gives no type); primary completion 2019-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 201 participants (enrolled count; ClinicalTrials.gov record NCT02802306, source copy `cardio:ctgov-nct02802306-2021-04-05`, retrieved 2026-10-31)
- Start date: 2016-06 (registry gives no type) (ClinicalTrials.gov record NCT02802306, source copy `cardio:ctgov-nct02802306-2021-04-05`, retrieved 2026-10-31)
- Primary completion: 2019-05 (actual) (ClinicalTrials.gov record NCT02802306, source copy `cardio:ctgov-nct02802306-2021-04-05`, retrieved 2026-10-31)
- Completion: 2020-05 (actual) (ClinicalTrials.gov record NCT02802306, source copy `cardio:ctgov-nct02802306-2021-04-05`, retrieved 2026-10-31)
- Countries: Austria; Belgium; Germany; Switzerland (ClinicalTrials.gov record NCT02802306, source copy `cardio:ctgov-nct02802306-2021-04-05`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02802306-2021-04-05`, retrieved 2026-10-31)

## The registry's words

- Brief title: Tack Optimized Drug Coated Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries
- Acronym: TOBA III
- Condition: Peripheral Arterial Disease
- Intervention (Device): Tack Endovascular System
- Lead sponsor: Philips Clinical & Medical Affairs Global
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Philips Clinical & Medical Affairs Global (`cardio:org-philips-clinical-medical-affairs-global`)

## Provenance

Content hash: bd3c2e12af7d9aef5daa55854427a97748cdeaa51ca3f69f8c9f09206c2f7dd3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
